Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$16.95 - $27.04 $500,194 - $797,950
-29,510 Reduced 11.06%
237,294 $6.42 Million
Q1 2024

May 14, 2024

BUY
$11.38 - $19.03 $2.81 Million - $4.7 Million
247,196 Added 1260.69%
266,804 $4.89 Million
Q4 2023

Feb 12, 2024

SELL
$6.29 - $15.72 $21,637 - $54,076
-3,440 Reduced 14.93%
19,608 $240,000
Q3 2023

Nov 13, 2023

BUY
$14.99 - $32.65 $39,693 - $86,457
2,648 Added 12.98%
23,048 $345,000
Q2 2023

Aug 11, 2023

SELL
$29.76 - $46.14 $15.5 Million - $24.1 Million
-521,837 Reduced 96.24%
20,400 $662,000
Q1 2023

May 12, 2023

BUY
$38.09 - $57.79 $969,771 - $1.47 Million
25,460 Added 4.93%
542,237 $21.2 Million
Q4 2022

Feb 13, 2023

BUY
$40.54 - $56.2 $20.3 Million - $28.2 Million
501,029 Added 3181.54%
516,777 $27.3 Million
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $66,231 - $88,117
1,791 Added 12.83%
15,748 $709,000
Q2 2022

Aug 15, 2022

SELL
$28.03 - $45.8 $13,258 - $21,663
-473 Reduced 3.28%
13,957 $509,000
Q1 2022

May 16, 2022

SELL
$29.24 - $44.06 $7,807 - $11,764
-267 Reduced 1.82%
14,430 $595,000
Q4 2021

Feb 14, 2022

SELL
$39.32 - $61.61 $3,735 - $5,852
-95 Reduced 0.64%
14,697 $626,000
Q3 2021

Nov 15, 2021

BUY
$44.0 - $65.8 $121,264 - $181,344
2,756 Added 22.9%
14,792 $814,000
Q2 2021

Aug 17, 2021

SELL
$44.66 - $63.06 $19.3 Million - $27.2 Million
-431,091 Reduced 97.28%
12,036 $576,000
Q1 2021

May 17, 2021

SELL
$46.31 - $62.7 $18.1 Million - $24.5 Million
-390,284 Reduced 46.83%
443,127 $22.4 Million
Q4 2020

Feb 16, 2021

SELL
$55.51 - $69.94 $14.8 Million - $18.7 Million
-267,339 Reduced 24.29%
833,411 $52.5 Million
Q3 2020

Nov 16, 2020

BUY
$42.19 - $69.61 $770,642 - $1.27 Million
18,266 Added 1.69%
1,100,750 $74 Million
Q2 2020

Aug 14, 2020

BUY
$27.55 - $43.28 $4.2 Million - $6.6 Million
152,380 Added 16.38%
1,082,484 $45.3 Million
Q1 2020

May 15, 2020

BUY
$23.16 - $47.8 $14.1 Million - $29.1 Million
608,709 Added 189.4%
930,104 $29.3 Million
Q4 2019

Feb 14, 2020

SELL
$27.97 - $40.38 $84,049 - $121,341
-3,005 Reduced 0.93%
321,395 $13 Million
Q3 2019

Nov 14, 2019

BUY
$31.65 - $46.94 $2.69 Million - $3.99 Million
85,000 Added 35.51%
324,400 $10.6 Million
Q2 2019

Aug 14, 2019

BUY
$32.5 - $49.12 $7.78 Million - $11.8 Million
239,400 New
239,400 $11.6 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.